Freeslate Announces Enhancement to its Metal Impregnation System for Catalyst Synthesis

Freeslate, Inc., the leading provider of high throughput research solutions, today announced updates to its Metal Impregnation System (MIPS), part of its Core Module 3 (CM3) configurable automation system for preparing, processing, and testing chemically complex samples and mixtures. Refining and chemical conversion rely on heterogeneous catalysts, chemically complex formulations with complex structures, and mechanisms [...]

Trovagene, Inc. Announces Closing of $15 Million Registered Direct Offering of Common Stock

SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that it has closed a registered direct offering of $15 million of common stock at a price of $7.00 per share. The shares were sold directly to an institutional investor by the Company. Trovagene intends to use the net proceeds [...]

Hepregen Corporation Announces Appointment of Martin Joyce as Vice President and Chief Financial Officer

MEDFORD, Mass.-- Hepregen Corporation, developer of next-generation HepatoPacTM and HepatoMuneTM products, announced today the appointment of Martin J. Joyce as Vice President of Finance and Administration and Chief Financial Officer. This appointment adds a highly experienced expert in finance to Hepregen’s senior management team. Mr. Joyce arrives at Hepregen as a member of Danforth Advisors [...]

Life Technologies Enters into an Exclusive License and Supply Agreement for Dynabeads

CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced that the company has signed a long-term supply and exclusive licensing agreement with Novartis for immunotherapeutics involving T cells modified to express chimeric antigen receptors for the treatment of cancer. Life Technologies will provide the company's proprietary technology, Dynabeads® CD3/CD28 CTS™, which possess unique biological [...]

Siemens Unveils VersaCell X3 Solution at AACC 2013

Siemens Healthcare Diagnostics further expanded its industry-leading clinical laboratory automation portfolio¹ by unveiling VersaCell® X3 Solution² at the 2013 AACC and ASCLS Annual Meeting and Clinical Lab Expo in Houston, July 28 – August 1 (Booth #3449). The newest model of Siemens’s longstanding VersaCell System, the new VersaCell X3 Solution now offers even more ways [...]

Fluxion Biosciences Partners with Bulldog Bio for Flow Analysis Equipment

Fluxion Biosciences has teamed up with Bulldog Bio to bring its extensive line of flow cell instrumentation to research labs in the USA and Canada. Bulldog Bio will act as distributor for the BioFlux EZ and BioFlux 200 systems in North America. This exclusive relationship relies upon Bulldog Bio’s marketing expertise, established customer base and [...]

Bina Technologies picks up $1.75M to keep democratizing genomic analysis

Bina Technologies, a company aiming to make genome processing faster and cheaper, has accepted $1.75 million for its Series B round, which included $6.25 million from Sierra Ventures. Behind the new capital are Jerry Yang of AME Cloud Ventures and Mohsen Moazami of Columbus Nova Technology Partners.

HBIO Subsidiary Harvard Apparatus Regenerative Technology, Inc. Files Form 10 Registration Statement for Planned Spin-Off

HOLLISTON, Mass., -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its wholly-owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc., or HART, has filed an initial Form 10 Registration Statement ("Form 10") with the [...]

Rigaku and Emerald Bio announce strategic alliance to broaden customer solutions in protein crystallography

The Woodlands, TX. Rigaku, the leading supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallization reagent and consumable business, including the popular Wizard™ screens, from Emerald Bio, a world leader in protein science. In addition, both companies have agreed to work together to develop new products and solutions in the [...]

Mirus Announces Transfection Advance: TransIT-X2™ Dynamic Delivery System

Mirus Bio has expanded its transfection expertise with the development of the TransIT-X2™ Dynamic Delivery System, an innovative polymeric system for high efficiency nucleic acid delivery. TransIT-X2 can be used for independent or simultaneous delivery of DNA and siRNA. The TransIT-X2 Dynamic Delivery System offers researchers: • Efficiency—Exceptional broad spectrum transfection • Versatility—Cutting edge delivery [...]

Access IBO on Knowledge Center